The trading price of Affimed N.V (NASDAQ:AFMD) closed higher on Friday, January 17, and closing at $1.15, 6.48% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.05 and $1.16. In examining the 52-week
Affimed NV (AFMD) unveiled how its immunological therapy has helped treat Hodgkin’s lymphoma. Even though the news only concerns four patients, it was well-received by investors. On April 13, AFMD shares were worth $ 9.89. The stock had gained more than 24% during the week.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
